Alembic Pharmaceuticals consolidated net profit rises 20.40% in the September 2025 quarter
Sales rise 15.91% to Rs 1910.15 crore
Net profit of Alembic Pharmaceuticals rose 20.40% to Rs 184.71 crore in the quarter ended September 2025 as against Rs 153.41 crore during the previous quarter ended September 2024. Sales rose 15.91% to Rs 1910.15 crore in the quarter ended September 2025 as against Rs 1647.98 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales1910.151647.98 16 OPM %16.5314.52 -PBDT299.79238.06 26 PBT223.72167.55 34 NP184.71153.41 20Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 04 2025 | 3:51 PM IST